Julie Lemieux
- Oncology top 5%
- Cancer Risks and Factors 11
- HER2/EGFR in Cancer Research 10
- Cancer survivorship and care 10
- Cancer Treatment and Pharmacology 7
- Urology top 2%
- Dermatology top 2%
- Cancer Research top 10%
- Breast Cancer Treatment Studies 14
-
- Health Systems, Economic Evaluations, Quality of Life 12
-
- Metabolism, Diabetes, and Cancer 11
-
- Advanced Breast Cancer Therapies 6
- Co-authors
- Louise ProvencherElizabeth MaunsellPamela J. GoodwinLouise BordeleauKaren A. GelmonTimothy J. WhelanWendy R. ParulekarSophie Lauzier
- Cited by
- OncologyUrologyDermatology
- Journals
- Journal of Clinical Oncology (18 papers)Breast Cancer Research and Treatment (8 papers)Cancer Research (3 papers)
- Partner nations
- CanadaUnited StatesSwitzerland
In The Last Decade
Julie Lemieux
78 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 133
- Oncology 852
- Urology 165
- Dermatology 191
- Cancer Research 265
- Family Practice 17
Countries citing papers authored by Julie Lemieux
This map shows the geographic impact of Julie Lemieux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Lemieux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Lemieux more than expected).
Fields of papers citing papers by Julie Lemieux
This network shows the impact of papers produced by Julie Lemieux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Lemieux. The network helps show where Julie Lemieux may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Julie Lemieux, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 11 | |
| 7 | 2023 | 12 | |
| 8 | 2021 | 12 | |
| 9 | 2021 | 5 | |
| 10 | 2020 | 4 | |
| 11 | 2018 | 13 | |
| 12 | 2017 | 13 | |
| 13 | 2017 | 14 | |
| 14 | 2016 | 2 | |
| 15 | 2014 | 64 | |
| 16 | Alcohol and HER2 polymorphisms as risk factor for cardiotoxicity in breast cancer treated with trastuzumab. | 2013 | 59 |
| 17 | 2012 | 21 | |
| 18 | 2011 | 24 | |
| 19 | 2010 | 23 | |
| 20 | 2007 | 268 |
About Julie Lemieux
Julie Lemieux is a scholar working on Oncology, Family Practice, Cancer Research, Dermatology and Biological Psychiatry, having authored 83 papers that have together received 1.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (14 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers), Cancer Risks and Factors (11 papers), Metabolism, Diabetes, and Cancer (11 papers), HER2/EGFR in Cancer Research (10 papers), Cancer survivorship and care (10 papers), Cancer Treatment and Pharmacology (7 papers) and Advanced Breast Cancer Therapies (6 papers). The work is most often cited by research in Oncology (852 citations), Urology (165 citations), Dermatology (191 citations), Cancer Research (265 citations) and Family Practice (17 citations). Julie Lemieux has collaborated with scholars based in Canada, United States and Switzerland. Frequent co-authors include Louise Provencher, Elizabeth Maunsell, Pamela J. Goodwin, Louise Bordeleau, Karen A. Gelmon, Timothy J. Whelan, Wendy R. Parulekar, Sophie Lauzier, Jacques Brisson and Kathleen I. Pritchard. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Cancer Research, The Breast and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.